HKSecWiki新股資訊 2022年09月23日
11:06 PM EDT, 09/22/2022 (MT Newswires) -- $JENSCARE-B(09877.HK)$ is targeting to raise up to HK$232.6 million ($29.6 million) from its initial public offering in Hong Kong.
美國東部時間2022年09月22日晚上11：06(MT新聞通訊社)--$JENSCARE-B(09877.HK)$該公司計劃通過在香港的首次公開募股(IPO)籌集至多2.326億港元(合2960萬美元)。
The high-tech medical equipment provider launched Friday its IPO of 8,076,400 shares, to be priced in the range of HK$26.70 to HK$28.80 per share, according to a same-day filing.
根據同日提交的一份文件，這傢高科技醫療設備提供商上周五啟動瞭8,076,400股IPO，發行價將在每股26.70港元至28.80港元之間。
The company expects to determine the price of the IPO on Sept. 29. The company will disclose the results on Oct. 7, in time for its trading debut on the stock exchange on Oct. 10.
該公司預計將於9月9日確定IPO價格。29.該公司將於10月7日公佈業績，趕在10月10日在證券交易所首次亮相。
Proceeds from the offering will be used for research and development, manufacturing and commercialization of its LuX-Valve and Ken-Valve products. It will also use part of the funding for working capital and general corporate purposes.
此次發行所得資金將用於其Lux-Valve和Ken-Valve產品的研發、制造和商業化。它還將把部分資金用於營運資金和一般企業用途。
The company attracted $LIFETECH SCI(01302.HK)$ as a cornerstone investor.
該公司吸引瞭$LifeTech SCI(01302.HK)$作為基石投資者。
China International Capital Corp., Citigroup, Huatai Financial Holdings, ABCI Capital, BOCOM International Securities, Futu Securities International, and Tiger Brokers are the joint bookrunners and lead managers of the IPO.
中金公司、花旗集團、華泰證券金控、ABCI Capital、交銀國際證券、富途證券國際和老虎經紀公司是此次IPO的聯席簿記管理人和牽頭經辦人。
本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠，亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。
Was this helpful?
0 / 0
本文链接： https://hk.hksecwiki.com/news/hkp19807409/
由HKSecWiki香港券商百科整理发布，香港证券开户请访问hksecwiki.com